Cite
Cardiovascular disease after treatment for Hodgkin's lymphoma
MLA
Maraldo, M. V., et al. “Cardiovascular Disease after Treatment for Hodgkin’s Lymphoma.” Lancet Haematology, vol. 2, no. 11, Nov. 2015, pp. E492–502. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10447af9fa970bcf9d08902b6d40bc36&authtype=sso&custid=ns315887.
APA
Maraldo, M. V., Giusti, F., Vogelius, I. R., Lundemann, M., Kaaij, M. A. van der, Ramadan, S., Meulemans, B., Henry-Amar, M., Aleman, B. M., Raemaekers, J. M. M., Meijnders, P., Moser, E. C., Kluin-Nelemans, H. C., Feugier, P., Casasnovas, O., Fortpied, C., & Specht, L. (2015). Cardiovascular disease after treatment for Hodgkin’s lymphoma. Lancet Haematology, 2(11), E492–E502.
Chicago
Maraldo, M.V., F. Giusti, I.R. Vogelius, M. Lundemann, M.A. van der Kaaij, S. Ramadan, B. Meulemans, et al. 2015. “Cardiovascular Disease after Treatment for Hodgkin’s Lymphoma.” Lancet Haematology 2 (11): E492–502. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....10447af9fa970bcf9d08902b6d40bc36&authtype=sso&custid=ns315887.